Android app Apple app link

IGC Pharma expands CALMA trial with addition of Butler Hospital Program

By Yahoo! Finance   |   2 weeks ago
IGC Pharma expands CALMA trial with addition of Butler Hospital Program

IGC Pharma expands Phase 2 CALMA trial with Butler Hospital, focusing on IGC-AD1 therapy for agitation in Alzheimer's disease. Dr. Meghan Riddle from Brown University to lead the trial, aiming to enroll 146 participants in the U.S.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.